← Eichor
Study identifier: NCT06489782 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Developing a Novel Human Laboratory Paradigm for AUD Medication Screening

Condition: Alcohol Use Disorder  ·  Sponsor: Yale University

PhaseNA
Planned participants90
Who can joinAll sexes, 21 Years to 65 Years
Healthy volunteersYes

About this study

The intent of the study is to develop two versions of the 'ability to resist' drinking model designed to screen Alcohol Use Disorder (AUD) medications.

This description comes directly from the study's public registry record.

Talk to the study team

Meaghan Lavery  ·  203-737-2783  ·  meaghan.lavery@yale.edu

Sabrina Coppola  ·  203-737-2827  ·  sabrina.coppola@yale.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Yale UniversityNew Haven, Connecticut, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06489782